Wed, Apr 23, 2014, 9:10 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Financial News From Zacks Small Cap Research

  • By Steven Ralston, CFA NYSE:DEJ The last few weeks have provided a great deal of color on the progress of Dejour Energy (NYSE:DEJ), along with management’s plans for 2014. During a recent conference call, ...

  • BLFS: Biologistex Offers Complementary Revenue Opportunity Zacks Small Cap Research - 9 hours ago

    BLFS To Launch New Thermal Shipper Tracking & Monitoring Service  Yesterday (4/22/14) BioLife Solutions (BLFS) announced that they will launch a new thermal shipping monitoring and tracking service called "biologistex".  The official launch will happen this week at the 20th ISCT Annual Meeting in Paris.  The service encompasses …

  • CPKF: Reducing 2014 EPS Estimate Zacks Small Cap Research - Tue, Apr 22, 2014 1:00 PM EDT

    By Ann Heffron, CFA, CPA OTC:CPKF We are slicing our 2014 diluted EPS estimate for Chesapeake Financial Shares, Inc. (OTC:CPKF) by $0.25 to $1.70 from $1.95 primarily for two reasons. Click here to download ...

  • DARA: Mea Culpa - Downgrading DARA Bio Zacks Small Cap Research - Mon, Apr 21, 2014 5:00 PM EDT

    Last week, DARA BioSciences, Inc. (DARA) filed an amended Form S/1 with the U.S. SEC announcing its intension to raise up to $20 million in cash over the very near-term. The offering will be led by Ladenburg Thalmann and H.C. Wainwright & Co. We remind investors that the company just recently raised $6.0 million in February …

  • CTTC: 10-K Filed. Maintaining Rec / Price Target Zacks Small Cap Research - Thu, Apr 17, 2014 11:00 AM EDT

    Cash used in operating activities was $294k and $1.6M in the three and twelve month periods ending 12/31/2013.  Ex-changes in working capital, which included a $158k decrease in prepaid expenses and a $125k increase in A/P in Q4, cash used in operating activities was $525k and $2.3M, respectively.  CTI exited 2013 with …

  • VTEQ 10-K Filed, Maintaining Outperform Rating Zacks Small Cap Research - Thu, Apr 17, 2014 7:00 AM EDT

    By Brian Marckx, CFA OTC:VTEQ 2013 10-K Filed   VeriTeQ (OTC:VTEQ) filed their 10-K for the period ending December 31, 2013 on April 15th.   Initial revenue amounting to $18k from sale of the Q Inside ...

  • BMRA: Top Line Rebound Even Better Than Expected Zacks Small Cap Research - Tue, Apr 15, 2014 1:00 PM EDT

    By Brian Marckx, CFA OBB:BMRA Q3 Results : Revenue Returns To Positive Growth On Strong Sales In Asia and U.S. Biomerica Inc (OBB:BMRA) filed their 10-Q for the fiscal third quarter ending February 28, ...

  • NWTR: 10K filed, 4Q13 updated. Zacks Small Cap Research - Tue, Apr 15, 2014 7:00 AM EDT

    By Ian Gilson, PhD, CFA OTC:NWTR On April 14, 2014 the company (OTC:NWTR) filed the 10K for 2013 that had been delayed from March 30, 2014. Since the financial data was for the full year the fourth quarter ...

  • NHC.TO: Zacks reviews of Northstar Healthcare’s strategy and 2013 results Zacks Small Cap Research - Mon, Apr 14, 2014 10:00 AM EDT

    Northstar Healthcare (NHC.TO) holds interests in and operates four ambulatory surgical centers (ASCs) in Houston, Dallas and Scottsdale. The company has experienced a dramatic increase in revenues over the last several quarters as a result of the implementation of management’s growth strategy composed of enhanced Direct-to-Consumer …

  • Zecotek: Maintaining Outperform Rating Zacks Small Cap Research - Wed, Apr 9, 2014 2:00 PM EDT

    Zecotek Photonics (ZMS.V) (ZMSPF) filed their financials for their fiscal 2014 second quarter ending January 31, 2014.  Revenue remains tepid, coming in at just $41k and again clearly did not reflect the initial $500k order from Hamamatsu for the scintillation crystals which was placed near the end of July 2013 or the $1.5M …

  • VNRX: Clinical Data Looks Promising For Colon Cancer Opportunity Zacks Small Cap Research - Wed, Apr 9, 2014 10:00 AM EDT

    Excluding the $350k impairment charge Q4 operating expenses were $1.3M, compared to our $1.2M estimate.  The asset impairment charge relates to a patent licensed by VNRX for their HyperGenomics assay (i.e. – unrelated to the core NuQ tests) – VNRX took the $350k write-down as it was discovered that an unrelated entity …

  • GRDH: Guardian 8 reports 2013 results, pilot program announced, incident documented Zacks Small Cap Research - Mon, Apr 7, 2014 9:00 AM EDT

    Guardian 8 Holdings (GRDH) reported results for the year ending December 31, 2013. The assessment of the Pro V2 device during real-life security situations should bolster the product’s claims as a layered defense system in terms of applicability, usability and effectiveness, especially with the device’s distinctive ability …

  • OPRX: Record Qtr and Yr But 2014 Could Dwarf 2013 Numbers Zacks Small Cap Research - Fri, Apr 4, 2014 4:00 PM EDT

    For the full-year 2013 revenue came in at $5.0M, up 149% from the $2.0M generated in 2012 with coupon redemptions more than quintupling over that same period.  We think the difference between the 1.5x revenue growth and ~5.0x coupon redemptions growth relates at least in part to a higher % of set-up revenue being booked …

  • CTSO: Record Sales in Q4 But Even Bigger Plans for 2014 Zacks Small Cap Research - Fri, Apr 4, 2014 8:00 AM EDT

    CytoSorbents (CTSO) reported results for the fourth quarter ending December 31, 2013 and as expected following the Q4 revenue pre-announcement in mid-January, product sales came in at an all-time high with total revenue missing the quarterly record by less than $2k.  While product sales came in about $16k shy of the low …

  • Sorrento: Multiple Progresses Have Been Made Zacks Small Cap Research - Thu, Apr 3, 2014 7:00 AM EDT

    On March 31, 2014, Sorrento Therapeutics (SRNE) announced that the first patient has been dosed in the pivotal clinical trial of Cynviloq for the treatment of metastatic breast cancer and non-small cell lung cancer.

  • 90% Enrollment Complete. $10M Financing Gets SNWV to PMA Submission. Zacks Small Cap Research - Wed, Apr 2, 2014 4:00 PM EDT

    On April 1st SANUWAVE (SNWV) announced financial results for the fourth quarter ending December 31, 2013.  Revenue came in better than our estimate, as did gross margin and operating expenses.  The much lower operating expenses in particular resulted in operating income about $867k (41%) better than our estimate.  And …

  • Consumables Growth Continues Despite Weaker Consoles Sales Zacks Small Cap Research - Wed, Apr 2, 2014 11:00 AM EDT

    Revenue came in lower than our expectations, was down almost 58% yoy and was at the lowest level of any quarter since Q2 2012.  But while total revenue disappointed in Q4, top-line results weren’t all bad with consumables sales (which should be the long-term driver of revenue) holding up nicely and posting double-digit …

  • Brazil Resources Primed to Attain Milestones in 2014 Zacks Small Cap Research - Wed, Apr 2, 2014 10:00 AM EDT

    By Steven Ralston OTC:BRIZF OVERVIEW: Brazil Resources Inc. (OTC:BRIZF) is a gold exploration company focused on the acquisition and development of a portfolio of gold projects, primarily in Brazil. Management ...

  • PBIO: Growth Momentum Will Continue in 2014 and Beyond Zacks Small Cap Research - Wed, Apr 2, 2014 8:00 AM EDT

    On April 1, 2014, Pressure BioSciences (PBIO) presented strong financial results for 4Q13 and fiscal year ended December 31, 2013. ·         Total revenue for 4Q13 was $354,052, compared to $216,032 for the same period in 2012, an increase of 64%. ·         Sales of consumables were $52,968 for 4Q13, compared to $18,624 …

  • ROSG: Three Platforms Will Drive Revenue Growth in 2014 and Beyond Zacks Small Cap Research - Wed, Apr 2, 2014 8:00 AM EDT

    On March 31, 2013, Rosetta Genomics (ROSG) reported financial results for the year ended December 31, 2013. Rosetta is also developing microRNA-based therapeutics.

  • CDTI: Adjusting estimates and target price for stock offering. Zacks Small Cap Research - Wed, Apr 2, 2014 7:01 AM EDT

    By Ian Gilson, CFA, PhD NASDAQ:CDTI Clean Diesel (NASDAQ:CDTI) has announced the sale of 2.03 million shares of stock at a price of $3.40 and warrants for 0.812 million shares. Since these, and other, ...

  • Titan & Braeburn Prep Next Steps With Probuphine Zacks Small Cap Research - Wed, Apr 2, 2014 7:00 AM EDT

    On March 31, 2014, Titan Pharmaceuticals (TTNP) reported financial results for the fourth quarter and full year ending December 2013. Revenues related to amortization of upfront payments from Probuphine commercialization partner, Braeburn Pharmaceuticals. For the full year 2013, Titan reported total revenues of $10.5 …

  • By Ian Gilson, CFA, PhD NASDAQ:CDTI On March 31, 2014 CDTi (NASDAQ:CDTI) announced its fourth quarter results. Revenue was close to expectations at $15.2A versus $15.5E. Operating income as reported was ...

  • Has Revenue Finally Bottomed At Zynex? Zacks Small Cap Research - Fri, Mar 28, 2014 8:00 AM EDT

    Zynex (ZYXI) reported financial results for the fourth quarter ending December 31, 2013.  Q4 revenue dropped dramatically from the prior period, was down over 68% from the yoy comparable quarter and was at the lowest level since Q3 2008.  The weakness experienced in the first nine months of the year due to recent changes …

  • Revenue Slumps But Not Expected To Be Long-Term Trend Zacks Small Cap Research - Wed, Mar 26, 2014 1:00 PM EDT

    Q1 EPS was $0.03, compared to our $0.05 estimate.  The miss on EPS was a result of a combination of the lower than expected revenue and higher than expected SG&A expense.  SG&A expense of $1.5M equaled 22% of revenue while we were looking for SG&A of 17% of revenue.  PBSV has been increasing spending on business development …

  • AVT: A Look at Recent Results Zacks Small Cap Research - Wed, Mar 26, 2014 12:30 PM EDT

    AVT (AVTC) is a technology company focused on the automated retail industry. Over the past roughly five years, management has developed new technologies and built self-service kiosks for automated vending. Today, automated retail machines sell a wide range of products including clothing, foods, high end electronics and …

  • Zacks raises target on ENSERVCO’s reporting of 2013 results Zacks Small Cap Research - Wed, Mar 26, 2014 8:15 AM EDT

    On March 20th, Enservco (ENSV) reported record fourth quarter and full-year revenues for 2013. Revenues and earnings set records for both the fourth quarter and the year. Despite the very strong topline and some pressure on the gross margin due to high propane costs in the Denver-Julesburg (D-J) Basin during the month …

  • FMD: Second Quarter Much Better than Expected on Reduced Operating Costs Zacks Small Cap Research - Wed, Mar 26, 2014 8:00 AM EDT

    The First Marblehead Corporation (FMD) reported its fiscal 2014 second quarter results for the period ended December 31, 2013, posting a net loss of $7.6 million, or a loss per share of $0.68 (all EPS data have been adjusted for the 1-for-10 reverse stock split in early December). FMD also announced the sale of up to …

  • Strong Launch of PerioPredict Zacks Small Cap Research - Mon, Mar 24, 2014 9:45 AM EDT

    Interleukin (ILIU) reported financial results for the fourth quarter and year ending December 31, 2013.  While revenue was ahead of our number, a jump in SG&A expense related to supporting the roll-out of the PST test resulted in a larger than estimated net loss.  More significant as far as the bigger picture, however, …

  • ForceField Energy focused on LED lighting, ORC projects and smart meters Zacks Small Cap Research - Mon, Mar 24, 2014 9:30 AM EDT

    ForceField Energy (FNRG) is pursuing opportunities in the green technology industries of LED lighting, ORC (Organic Rankin Cycle) technology and smart meters. In February, ForceField broadened its LED effort with the acquisition of Catalyst LED, a provider of LED lighting products and solutions. ForceField’s management …

  • PBIO: On Track to Launch Two New Products in 1H14 Zacks Small Cap Research - Thu, Mar 20, 2014 7:00 AM EDT

    Specifically, we predicted that the HUB880 will be launched during 1Q14 and the High Throughput Barocycler will be launched in June 2014. On March 19, 2014 announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also …

  • GeoVax: Moving forward with both preventive and therapeutic HIV vaccine programs Zacks Small Cap Research - Wed, Mar 19, 2014 7:00 AM EDT

    For the fiscal year ending Dec 31, 2013, GeoVax generated grant revenues of $2.4 million. At December 31, 2013, GeoVax held $2.5 million in cash, compared to $1.0 million at December 31, 2012. On Jan 13, 2014, GeoVax announced preliminary top-line results from GV-TH-01, a Phase I clinical trial investigating the ability …

  • PURE: Revenue growth will resume in calendar 2H14 Zacks Small Cap Research - Mon, Mar 17, 2014 12:00 PM EDT

    PURE’s flagship bioscience technology is a patented, aqueous antimicrobial called silver dihydrogen citrate (SDC). SDC is a new molecular entity, and is an electrolytically generated source of stabilized ionic silver that can serve as the basis for a broad range of products in diverse markets. SDC liquid is colorless, …

  • DelMar: Ready to Initiate Registrational Phase II of VAL-083 Zacks Small Cap Research - Fri, Mar 14, 2014 3:14 AM EDT

    By Grant Zeng, CFA OBB:DMPI ·          Updated interim Phase I/II Clinical data of VAL-083 will be presented at AACR; ·          Registration directed Phase II and Phase II/III trials will begin in 1H2014; ...

  • Rosetta Genomics: Pipeline Provides Sustainable Growth Zacks Small Cap Research - Wed, Mar 12, 2014 11:00 AM EDT

    Earlier today in a news release, Rosetta Genomics (ROSG) provided update on its product pipeline based on its proprietary microRNA platform technologies.  The company is developing microRNA based-molecular diagnostics and therapeutics. MicroRNA based Molecular Diagnostics Rosetta is currently marketing four cancer diagnostics: …

  • (CDTI) to produce catalysts for the TLX, the replacement for Acura's most popular vehicles. CDTi (CDTI) has announced that it will provide MPC catalysts for Honda's Acura TLX, the new replacement for the Acura TL and TSX. These are Acura's most popular vehicles, with production data as shown below.

  • Labor Smart (LTNC): Resemblance to Early Stage True Blue Zacks Small Cap Research - Tue, Mar 11, 2014 11:53 AM EDT

    Labor Smart (LTNC): Resemblance to Early Stage True Blue Parallels to Emerging TBI  Comparing Labor Smart (OTC BB:LTNC) to staffing company True Blue (TBI-not rated) during its early days shows significant ...

  • GeneNews: Revenue Growth Will Accelerate In 2014 Zacks Small Cap Research - Tue, Mar 11, 2014 10:00 AM EDT

    -Revenue from IDL is ramping up quickly; -Revenue growth will accelerate in 2014 and beyond; Revenue from IDL Is Ramping Quickly   On March 4, 2014, GeneNews Limited (TOR:GEN.TO) reported operational and financial results for the three-month and full-year periods ended December 31, 2013.The company reported revenue of …

  • CEMI: Solid 2013. HIV/Syphilis Test A Potential Needle-Mover Zacks Small Cap Research - Mon, Mar 10, 2014 6:00 AM EDT

    Chembio's (CEMI) Q4 and full year 2013 revenue of $7.9 million and $29.6M was essentially flat and up 15% from the same respective periods in 2012.  For the quarter, DPP sales eked out a 2% gain and lateral flow sales fell about $350k (8%) which was mostly offset by a $306k increase in non-product revenue.  The catalyst …

  • NWTR: Acquisition of more acres in Oklahoma. Zacks Small Cap Research - Fri, Mar 7, 2014 3:00 PM EST

    New Western Energy (OTC:NWTR) has acquired a 217 acres project in Nowata County OK. This project is currently producing gas from 20 production wells on the Taylor lease and there are three saltwater wells used to dispose of water used in water flooding to pressurize the production wells. The Moab project joins the other …

  • CPKF: Fourth Quarter Hit by Higher Loss Provision and Noninterest Expense Zacks Small Cap Research - Fri, Mar 7, 2014 11:00 AM EST

    Chesapeake Financial Shares, Inc.’s (CPKF) fourth quarter net earnings fell 9% to $1.2 million, while 2013’s fourth quarter diluted EPS slumped by $0.03, or 9%, to $0.36 from $0.39 posted in 2012’s fourth quarter.

  • Update on Boa Fé, Tabuaço and Middle East initiatives of Colt Resources Zacks Small Cap Research - Fri, Mar 7, 2014 6:00 AM EST

    Colt Resources (GTP.V) (COLTF) (P01.F) is a Canadian junior gold exploration company with numerous mineral exploration properties in Portugal, including two advanced stage projects in Portugal: the Boa Fé gold project and the Tabuaço tungsten project. Colt Resources has also successfully incubated, incorporated and launched …

  • Rosetta Genomics (ROSG) - Initiating with an Outperform Zacks Small Cap Research - Thu, Mar 6, 2014 8:10 AM EST

    Zacks Small Cap Research Initiates on Rosetta Genomics (NasdaqCM:ROSG) with a Outperform Recommendation.  Grant Zeng, CFA & Senior Biotech Analyst at Zacks Small Cap Research Initiates Coverage: Grant ...

  • CDTi (Nasdaq CM:CDTI) Most heavier trucks and buses are required to have a PM (Particulate Matter) filter fitted by Jan. 01, 2014. ARB will recognize good faith efforts to comply and provide early access to regulatory changes providing actions to comply were reported through the reporting system by Jan. 01, 2014. Those …

  • TPNI Shares are a Way to Play the Expanding Digital Marketing Sector Zacks Small Cap Research - Tue, Mar 4, 2014 12:00 PM EST

    We believe shares of The Pulse Network (OTC BB:TPNI) offer a means of gaining exposure to the rapidly growing digital marketing sector. In turn, this has boosted the importance of online interaction with potential customers, making digital marketing increasingly more germane. Rapid sector growth has been driven by an …

  • Petaquilla announces disappointing FY2Q results but expects material event Zacks Small Cap Research - Tue, Feb 25, 2014 3:00 PM EST

    Last week on February 17th, Petaquilla Minerals (PTQ.TO) and (PTQMF) filed second fiscal quarter results for the period ending December 30, 2013. Gold equivalent production declined 67.0% sequentially from 9,452 ounces to 3,120 ounces despite an easy comparison. Management also cited general maintenance of the Molejón …

  • S&W Seed: Short term lines of credit now in place for a total of $14 million. Zacks Small Cap Research - Tue, Feb 25, 2014 5:30 AM EST

    S&W Seed (SANW) has entered into a credit agreement with Well Fargo Bank for a new working capital agreement for $4 million in domestic credit and $10 million for export related accounts receivables and inventory. These are normal working capital lines of credit  except the facilities are backed by a lien on the stock …

  • QCRH: Messy Fourth Quarter, But QCRH Is All Set for 2014 Zacks Small Cap Research - Mon, Feb 24, 2014 5:30 AM EST

    QCR Holdings, Inc. (QCRH) reported 2013 fourth quarter diluted EPS of $0.50, including a couple of partially offsetting items: a pretax $2.3 million gain on the sale of four CNB branches and a pretax $1.2 million charge for the CNB acquisition and data conversion costs. In addition, QCRH had a few other nonrecurring items, …

  • ForceField Energy advantageously exits trichlorosilane operations Zacks Small Cap Research - Mon, Feb 24, 2014 5:00 AM EST

    On February 19th, ForceField Energy (FNRG) entered into Equity Transfer Agreements to divest its 90% equity interest in Zibo Baokai Commerce and Trade Co., Ltd. and its 60% equity interest in Wendeng He Xie Silicon Co. Ltd. to the minority owners of businesses, effectively discontinuing the company’s trichlorosilane (TCS) …

  • S&W Seed: Dramatic improvement in operating margins drives profits. Zacks Small Cap Research - Fri, Feb 14, 2014 5:00 AM EST

    On February 13, 2014 S&W Seed (SANW) announced its second fiscal quarter results. Other factors were lower selling prices as more seed from Australia was sold and the US dollar strengthened versus the Australian dollar. Although 40% of the revenue was derived from blended varieties (from California and Australia) we believe …

Next >>